AxoGen, Inc. (AXGN) financial statements (2021 and earlier)

Company profile

Business Address 13631 PROGRESS BLVD.
ALACHUA, FL 32615
State of Incorp. MN
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments104 117373026
Cash and cash equivalents49 24373026
Short-term investments55 92   
Receivables18 151185
Inventory, net of allowances, customer advances and progress billings13 12754
Inventory13 12754
Prepaid expense4     
Other undisclosed current assets8 7110
Total current assets:145 151564435
Noncurrent Assets
Finance lease, right-of-use asset0 
Operating lease, right-of-use asset16 
Property, plant and equipment38 8211
Intangible assets, net (including goodwill)2 1111
Intangible assets, net (excluding goodwill)2 1111
Deferred costs     1
Total noncurrent assets:56 9322
TOTAL ASSETS:201 160594638
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22 13974
Accounts payable5 5342
Accrued liabilities4 22 0
Employee-related liabilities14 6432
Deferred revenue0 
Debt0 010 
Deferred revenue and credits000
Contract with customer, liability0
Other undisclosed current liabilities1  44 
Total current liabilities:23 1314114
Noncurrent Liabilities
Long-term debt and lease obligation32 0202026
Long-term debt, excluding current maturities32 0202026
Liabilities, other than long-term debt3 0000
Deferred revenue and credits000
Contract with customer, liability0
Other liabilities0 0   
Derivative instruments and hedges, liabilities2     
Other undisclosed noncurrent liabilities21     
Total noncurrent liabilities:55 0202026
Total liabilities:78 13343129
Stockholders' equity
Stockholders' equity attributable to parent123 14725158
Common stock0 0000
Additional paid in capital326 297153132111
Accumulated deficit(204) (151)(128)(118)(103)
Total stockholders' equity:123 14725158
TOTAL LIABILITIES AND EQUITY:201 160594638

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues112 84604127
Cost of revenue
(Cost of Goods and Services Sold)
(22) (13)(9)(6)(5)
Gross profit:91 71513522
Operating expenses(114) (92)(59)(43)(32)
Operating loss:(23) (21)(8)(8)(9)
Nonoperating expense(1) (2)(2)(6)(4)
Investment income, nonoperating0 2   
Interest and debt expense(1) (2)(2)(5)(4)
Net loss:(25) (25)(13)(20)(17)
Other undisclosed net income attributable to parent1 2254
Net loss available to common stockholders, diluted:(24) (22)(10)(14)(13)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(25) (25)(13)(20)(17)
Comprehensive loss, net of tax, attributable to parent:(25) (25)(13)(20)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: